Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ DPP2 Monoclonal Antibody (398011)

Rat Monoclonal Antibody

Supplier:  Invitrogen™ MA524133

Catalog No. PIMA524133


Only null left
Add to Cart

Description

Description

Reconstitute at 0.5 mg/mL in sterile PBS. Endoxin level is <0.10 EU per 1 μg of the antibody by the LAL method.

The protein encoded by this gene is a post-proline cleaving aminopeptidase expressed in quiescent lymphocytes. The resting lymphocytes are maintained through suppression of apoptosis, a state which is disrupted by inhibition of this novel serine protease. The enzyme has strong sequence homology with prolylcarboxypeptidase and is active at both acidic and neutral pH.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

DPP2
Monoclonal
0.5 mg/mL
PBS with 5% trehalose and No Preservative
Q9UHL4
DPP7
Mouse myeloma cell line NS0-derived recombinant human DPPII/QPP/DPP7 Gly22-Leu492.
100 μg
Primary
Human
Antibody
IgG2a
Neutralization
398011
Unconjugated
DPP7
carboxytripeptidase; dipeptidyl aminopeptidase II; dipeptidyl arylamidase II; dipeptidyl peptidase 2; Dipeptidyl peptidase 7; dipeptidyl peptidase II; dipeptidyl-peptidase 2; dipeptidylpeptidase 7; dipeptidyl-peptidase II; DPP II; DPP2; Dpp7; DPPII; QPP; Quiescent cell proline dipeptidase
Rat
Protein A/G
RUO
29952
-20°C, Avoid Freeze/Thaw Cycles
Lyophilized
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.